These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9820005)

  • 1. [Peroxisomes and peroxisome proliferators. Specific environmental poisons and therapeutic agents affecting lipid metabolism and hormone release].
    Hammer TA; Waldum HL
    Tidsskr Nor Laegeforen; 1998 Sep; 118(23):3603-8. PubMed ID: 9820005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic peroxisome proliferation in rodents and its significance for humans.
    Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
    Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D
    Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation.
    Vanden Heuvel JP
    Gen Pharmacol; 1996 Oct; 27(7):1123-9. PubMed ID: 8981056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease.
    Youssef J; Badr M
    Crit Rev Toxicol; 1998 Jan; 28(1):1-33. PubMed ID: 9493760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.
    Reddy JK; Lalwai ND
    Crit Rev Toxicol; 1983; 12(1):1-58. PubMed ID: 6360536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal lipid metabolism.
    Reddy JK; Mannaerts GP
    Annu Rev Nutr; 1994; 14():343-70. PubMed ID: 7946524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
    Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
    Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferators: paradigms and prospects.
    Gibson GG
    Toxicol Lett; 1993 May; 68(1-2):193-201. PubMed ID: 8390728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferators: a model for receptor mediated carcinogenesis.
    Green S
    Cancer Surv; 1992; 14():221-32. PubMed ID: 1330305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and biogenesis of peroxisomes.
    Chandoga J
    Bratisl Lek Listy; 1994 Dec; 95(12):543-57. PubMed ID: 7735895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
    Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
    Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
    Bojes HK; Thurman RG
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically induced proliferation of peroxisomes: implications for risk assessment.
    Stott WT
    Regul Toxicol Pharmacol; 1988 Jun; 8(2):125-59. PubMed ID: 3051140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferators: their biological and toxicological effects.
    Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
    Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The contribution of peroxisomes to lipid metabolism].
    Kramar R
    J Clin Chem Clin Biochem; 1986 Feb; 24(2):109-18. PubMed ID: 3711795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
    Lake BG
    Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
    Reddy JK; Rao MS
    Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of rodent liver carcinogenesis.
    Michalopoulos GK; Eckl PM; Cruise JL; Novicki DL; Jirtle RL
    Toxicol Ind Health; 1987 Jun; 3(2):119-28. PubMed ID: 3303445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.